High-dose therapy and autografting with peripheral blood stem cells in malignant lymphoma: granulocyte-macrophage colony-stimulating factor for stem cell mobilization.
Haas
R
R
Department of Internal Medicine V, University of Heidelberg, Germany.
Hohaus
S
S
Goldschmidt
H
H
Möhle
R
R
Witt
B
B
Wannenmacher
M
M
Hunstein
W
W
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016465:Bone Marrow Purging; D017024:Chemotherapy, Adjuvant; D018572:Disease-Free Survival; D005260:Female; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000276:immunology; D006801:Humans; D007377:Interleukin-3 / Q000627:therapeutic use*; D007937:Leukapheresis; D008223:Lymphoma / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
D000970:Antineoplastic Agents; D007377:Interleukin-3; D016178:Granulocyte-Macrophage Colony-Stimulating Factor